eribulin mesylate,ecteribulin,farletuzumab
bms,eisai pharmaceutical
['eribulin', 'farletuzumab', 'farletuzumab,ecteribulin', '$esaly', 'eisai']
$esaly eisai presents new findings for antibody drug conjugate farletuzumab ecteribulin at 2022 asco annual meeting 
News and analysis of biomedical, biopharma, biotech, biosciences, pharmaceutical, and technology equities